亚宝药业：累计回购公司股份800万股

Group 1 - The core point of the article is that Yabao Pharmaceutical (600351) announced a share buyback program, having repurchased a total of 8,000,000 shares, which represents 1.14% of the company's total share capital as of October 30, 2025 [1]